The results support the possibility that, in vivo, the ability of palmitate to induce insulin resistance may include activating macrophages to secrete proinflammatory cytokines and chemokines that would negatively impact on insulin action in skeletal muscle, acting through novel PKC's. The gene discussed is PRRT2; the disease is Insulin resistance.